Sponsor And CRO Finalists Announced For Annual Society For Clinical Research Sites Eagle Award

- AstraZeneca, Boehringer Ingelheim, Eli Lilly & Company, Ferring Pharmaceuticals, Inc., Forest Laboratories, Inc., GlaxoSmithKline, Novartis, Novo Nordisk, Pearl Therapeutics, Pfizer, Sanofi, Chiltern International, ICON plc, INC Research, inVentiv Health, Parexel International, Pharmaceutical Research Associates (PRA), Quintiles, and Target Health Inc.

ELLICOTT CITY, Maryland, Aug. 11, 2014 /PRNewswire/ -- The Society for Clinical Research Sites (SCRS), the trade organization representing over 1,500 global clinical research sites in 37 countries, announces today the finalists for the 2014 SCRS Eagle Award. The finalists were selected from a record number of nominations provided by SCRS members. Qualifying nominees received were in the 75th percentile or higher of the total nominations submitted for the Eagle Award. Voting is now open to all clinical research site professionals, and closes September 16, 2014.

The SCRS Eagle Award recognizes outstanding leadership, professionalism, integrity, passion and dedication to advancing the clinical research profession through a strong site partnership.

The 2014 sponsor nominees are: AstraZeneca, Boehringer Ingelheim, Eli Lilly & Company, Ferring Pharmaceuticals, Inc., Forest Laboratories, Inc., GlaxoSmithKline, Novartis, Novo Nordisk, Pearl Therapeutics, Pfizer and Sanofi.

The 2014 CRO nominees are: Chiltern International, ICON plc, INC Research, inVentiv Health, Parexel International, Pharmaceutical Research Associates (PRA), Quintiles, and Target Health Inc.

Christine Pierre, President of SCRS, states: "The Eagle Award nomination process, and the honor this award represents, generates great enthusiasm among SCRS members. Sites strive to work with companies that truly value them as a partner. There is no arbitrary inclusion criteria involved in the voting; the Eagle Award nominees are finalized wholly on input forthcoming directly from the sites, and the voice of the sites is being heard loud and clear: more nominations have been received this year than ever before. To SCRS, this signifies the eagerness among sites to appreciate and publicly recognize companies who demonstrate a strong commitment to the site partnership. SCRS sincerely congratulates all of the SCRS Eagle Award finalists."

Winners will be honored at the 2014 SCRS Eagle Award Gala on Saturday, October 11^th in Amelia Island, Florida during the annual Site Solutions Summit.

About SCRS

SCRS is the global trade organization which represents over 1,500 sites in 37 countries. SCRS' mission is to unify the voice of the global clinical research site community for site sustainability. SCRS has become an active partner in industry-wide dialogues focused on improving the clinical research enterprise among the many industry initiatives. Clinical research sites, as well as companies that sponsor or support the work conducted at the sites, will significantly benefit from membership. Visit www.myscrs.org

About the Site Solutions Summit

The Site Solutions Summit is the annual meeting of the Society for Clinical Research Sites. The Summit provides an open forum for industry and sites to collaborate, share best practices, and improve processes in clinical research. Held October 10-12 at the Omni in Amelia Island, FL, the Site Solutions Summit attracts investigators and site executives from research sites across the globe, as well as clinical operation executives from sponsor and CRO organizations.

SOURCE The Society for Clinical Research Sites